tiprankstipranks
Advertisement
Advertisement

MX:ABBV Stock Latest News

AbbVie Earnings Call: Growth Engines Outpace Legacy Drag
Company AnnouncementsAbbVie Earnings Call: Growth Engines Outpace Legacy Drag
2d ago
ABBV
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
PremiumThe Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
2d ago
CL
BSX
AbbVie says ‘quite pleased’ with Skyrizi momentum
PremiumThe Fly
AbbVie says ‘quite pleased’ with Skyrizi momentum
2d ago
ABBV
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
PremiumThe Fly
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
2d ago
ABBV
AbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
PremiumThe Fly
AbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
2d ago
ABBV
AbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
PremiumThe FlyAbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
2d ago
ABBV
AbbVie says continues to make ‘excellent progress’ advancing pipeline
Premium
The Fly
AbbVie says continues to make ‘excellent progress’ advancing pipeline
2d ago
ABBV
AbbVie reports Q2 adjusted EPS $3.65, consensus $3.61
Premium
The Fly
AbbVie reports Q2 adjusted EPS $3.65, consensus $3.61
2d ago
ABBV
AbbVie cuts FY26 adjusted EPS view to $13.87-$14.07 from $13.91-$14.11
PremiumThe Fly
AbbVie cuts FY26 adjusted EPS view to $13.87-$14.07 from $13.91-$14.11
2d ago
ABBV
AbbVie announces Elahere availability in Singapore
PremiumThe Fly
AbbVie announces Elahere availability in Singapore
4d ago
ABBV
AbbVie announces European Commission approval for Rinvoq
PremiumThe Fly
AbbVie announces European Commission approval for Rinvoq
4d ago
ABBV
AbbVie price target raised to $300 from $275 at Barclays
PremiumThe Fly
AbbVie price target raised to $300 from $275 at Barclays
4d ago
ABBV
Abbvie (ABBV) Q2 Earnings Cheat Sheet
PremiumPre-EarningsAbbvie (ABBV) Q2 Earnings Cheat Sheet
4d ago
ABBV
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
Premium
The Fly
Genmab, AbbVie provide clarification on Phase 3 EPCORE(R) DLBCL-1 trial
10d ago
ABBV
GMAB
AbbVie price target raised to $282 from $273 at Canaccord
Premium
The Fly
AbbVie price target raised to $282 from $273 at Canaccord
11d ago
ABBV
AbbVie: Neutral Stance Maintained as Fundamentals Improve and APGE-Driven Rally Leaves Valuation Fair; Price Target Reaffirmed at $244
PremiumRatingsAbbVie: Neutral Stance Maintained as Fundamentals Improve and APGE-Driven Rally Leaves Valuation Fair; Price Target Reaffirmed at $244
11d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >